Evidence map›Paper›PMID 40933980›Full record

ArticleTurkish journal of medical sciences2025

Metabolic and genotypic characterization of meropenem-susceptible and meropenem-resistant

Şeyma Nigiz, Gülşen Hazirolan, Gülşen Altinkanat Gelmez, Ceren Özkul, Engin Koçak, Sevilay Erdoğan Kablan, Emirhan Nemutlu, Aycan Gündoğdu, Fatma Bayrakdar, Ufuk Hasdemir and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Turkish journal of medical sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Şeyma NigizDepartment of Pharmaceutical Microbiology, Faculty of Pharmacy, Hacettepe University, Ankara, Turkiye.ORCID https://orcid.org/0000-0002-8354-5107
Gülşen HazirolanDepartment of Medical Microbiology, Faculty of Medicine, Hacettepe University, Ankara, Turkiye.ORCID https://orcid.org/0000-0003-4546-9729
Gülşen Altinkanat GelmezDepartment of Medical Microbiology, Faculty of Medicine, Marmara University, İstanbul, Turkiye.ORCID https://orcid.org/0000-0003-0274-628X
Ceren ÖzkulDepartment of Pharmaceutical Microbiology, Faculty of Pharmacy, Hacettepe University, Ankara, Turkiye.ORCID https://orcid.org/0000-0002-0921-5863
Engin KoçakDepartment of Analytical Chemistry, Gulhane Faculty of Pharmacy, University of Health Sciences, Ankara, Turkiye.ORCID https://orcid.org/0000-0002-1076-1300
Sevilay Erdoğan KablanDepartment of Analytical Chemistry, Faculty of Pharmacy, Hacettepe University, Ankara, Turkiye.ORCID https://orcid.org/0000-0002-6503-0142
Emirhan NemutluDepartment of Analytical Chemistry, Faculty of Pharmacy, Hacettepe University, Ankara, Turkiye.ORCID https://orcid.org/0000-0002-7337-6215
Aycan GündoğduDepartment of Medical Microbiology, Faculty of Medicine, Erciyes University, Kayseri, Turkiye.ORCID https://orcid.org/0000-0003-2806-8464
Fatma BayrakdarDepartment of VetMEd-Infectious Diseases, College of Veterinary Medicine, University of Georgia, GA, USA.ORCID https://orcid.org/0000-0001-7531-5080
Ufuk HasdemirDepartment of Medical Microbiology, Faculty of Medicine, Marmara University, İstanbul, Turkiye.ORCID https://orcid.org/0000-0002-1606-0804
Deniz GürDepartment of Medical Microbiology, Faculty of Medicine, Hacettepe University, Ankara, Turkiye.ORCID https://orcid.org/0000-0002-7504-8450

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background/aim: Materials and methods: A total of 84 Results: The highest resistance rate was observed for ceftriaxone (27.6%). Amikacin was the most effective drug, with a resistance rate of 6.9%. Overall, 10 (11.9%) isolates were resistant to meropenem. Genotyping of β-lactamase genes revealed that Conclusion: Understanding the metabolic profiles of

Indexed as

Anti-Bacterial AgentsDrug Resistance, BacterialMeropenemSerratia marcescensElectrophoresis, Gel, Pulsed-FieldGenotypeHumansMicrobial Sensitivity TestsSerratia InfectionsAnti-Bacterial AgentsMeropenemcarbapenemasesefflux pumpsmetabolomicsmicrodilutionpulsed-field gel electrophoresisSerratia marcescens

Identifiers

PMID40933980
PMCPMC12419042

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.